This decrease of de novo atherosclerosis in the absence of TRAF1 is accompanied by a lower content of macrophages and lipids in TRAF1-deficient plaques, an effect likely caused by reduced VCAM-1 and ICAM-1 expression on EC and reduced β1-integrin expression on macrophages. This evidence concerns the gene TRAF1 and atherosclerosis.